J.P. Morgan Annual Healthcare Conference 2025: trends and highlights you may have missed

Beyond Biotech - the podcast from Labiotech

This week, we take a look at some of the highlights from the 43rd Annual J.P. Morgan Healthcare Conference, which took place in San Francisco recently.

While there weren’t necessarily many financial blockbusters, there were plenty of announcements and discussions on everything from artificial intelligence to the rising influence of Chinese companies and research, to the potential ramifications of the incoming Trump administration in the U.S.

To help us navigate some of the highlights of the event, we spoke with Orca Bio’s co-founder and CEO, Ivan Dimov, and also Parabilis Medicines’ chief business officer, Greg Miller.

02:01-03:53: About Orca Bio
03:53-05:43: JPM highlights
05:43-07:26: Stand-out deals and announcements
07:26-09:01: Were any sectors more prominent than others?
09:01-12:38: About Parabilis Medicines
12:38-13:58: JPM highlights
13:58-16:33: Stand-out deals and announcements
16:33-17:53: Were any sectors more prominent than others?
17:53-19:17: Was there an optimistic mood?

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

Capíttulos

1. J.P. Morgan Annual Healthcare Conference 2025: trends and highlights you may have missed (00:00:00)

2. About Orca Bio (00:02:01)

3. JPM highlights
 (00:03:53)

4. Stand-out deals and announcements
 (00:05:43)

5. Were any sectors more prominent than others?
 (00:07:26)

6. About Parabilis Medicines
 (00:09:01)

7. JPM highlights
 (00:12:38)

8. Stand-out deals and announcements 
 (00:13:58)

9. Were any sectors more prominent than others?
 (00:16:33)

10. Was there an optimistic mood? (00:17:53)